Clinical trial
BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes
NCT00389402 · International Antiviral Therapy Evaluation Center, Other · Completed
Key facts
| NCT number | NCT00389402 |
|---|---|
| Title | BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes |
| Official title | A Randomised, Controlled, Open-Label, 48-Week, Study To Asses Differences in Changes In Plasma Lipid Profile Between Patients On Saquinavir/Ritonavir Or Atazanavir/Ritonavir In Combination With Tenofovir Disoproxil Fumarate And Emtricitabine As A First-line Regimen. |
| Lead sponsor | International Antiviral Therapy Evaluation Center, Other |
| Collaborators | Hoffmann-La Roche Industry Gilead Sciences |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | saquinavir/ritonavir, atazanavir/ritonavir |
| Enrollment | 120 |
| Start date | Jul 1, 2006 |
| Completion | Jul 1, 2008 |
| First posted | Oct 18, 2006 |
| Last update posted | Jun 11, 2010 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: